Table 2.

Biochemical characteristics of patients.

Biochemical characteristics	Control (n = 50)	CAD (n = 182)	p	SAP (n = 40)	NSTEACS (n = 90)	STEMI (n = 52)
TC (mmol/L)	4.45 ± 0.48	4.60 ± 0.57	0.082	4.55 ± 0.55	4.56 ± 0.52	4.72 ± 0.67
TG (mmol/L)	1.42 ± 0.33	1.58 ± 0.34	0.007∗∗	1.69 ± 0.35∗∗	1.52 ± 0.33	1.58 ± 0.35
HDL-C (mmol/L)	1.21 ± 0.17	1.17 ± 0.18	0.129	1.26 ± 0.15	1.19 ± 0.18	1.06 ± 0.16∗∗##&&
LDL-C (mmol/L)	2.39 ± 0.42	2.31 ± 0.58	0.344	2.32 ± 0.40	2.37 ± 0.36	2.19 ± 0.90
Lipoprotein(a) (mg/L)	38.37 ± 10.21	49.30 ± 9.84	<0.001∗∗	42.59 ± 9.27	48.13 ± 8.87∗∗##	56.51 ± 7.06∗∗##&&
FPG (mmol/L)	4.86 ± 0.44	5.41 ± 0.59	<0.001∗∗	5.28 ± 0.46∗∗	5.29 ± 0.52∗∗	5.76 ± 0.66∗∗##&&
Creatinine (mmol/L)	67.1 ± 16.1	75.8 ± 25.7	0.024∗	79.1 ± 36.5	70.4 ± 16.7	82.7 ± 27.0∗∗&
Uric acid (mmol/L)	345.6 ± 38.5	351.8 ± 41.0	0.342	369.1 ± 20.9∗	350.6 ± 38.5	340.7 ± 51.7##
hs-CRP (mg/L)	3.53 ± 0.26	5.54 ± 2.10	<0.001∗∗	3.42 ± 0.30	5.17 ± 1.01∗∗##	7.79 ± 2.20∗∗##&&
cTNI (ng/mL)	0.17 ± 0.06	9.04 ± 17.66	<0.001∗∗	0.20 ± 0.66	2.38 ± 6.25	27.40 ± 23.56∗∗##&&

^∗ p < 0.05 versus control,  ^∗∗ p < 0.01 versus control,  ^# p < 0.05 versus SAP,  ^## p < 0.01 versus SAP,  ^& p < 0.05 versus NSTEACS,  ^&& p < 0.01 versus NSTEACS.